Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP993215priorityCriticalpatent/ECSP993215A/en
Publication of ECSP993215ApublicationCriticalpatent/ECSP993215A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Una composición farmacéutica, cuya composición comprende: Un sensibilizador de insulina y otro agente antidiabético y un vehículo farmacéuticamente aceptable para el mismo, donde la composición está otro agente antidiabético, y el uso de tal composición en medicina.A pharmaceutical composition, the composition of which comprises: An insulin sensitizer and another antidiabetic agent and a pharmaceutically acceptable vehicle therefor, where the composition is another antidiabetic agent, and the use of such composition in medicine.
ECSP9932151999-11-111999-11-11
NEW COMPOSITION AND USE
ECSP993215A
(en)
USE OF AN INSULIN SENSITIZER AND AN ANTI-HYPERGLYCEMIC AGENT FOR THE PREPARATION OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH SENSITIZER AND SUCH AGENT.
Pharmaceutical composition comprising: i) an at1 receptor antagonist or a salt, ii) an insulin sensitizer or a salt and iii) a pharmaceutically acceptable carrier; use for the prevention, delay of progress or treatment of hypertension, diabetes, among others (div. sol. 2034-01).
USE OF AN INSULIN SENSITIZER AND AN ANTIHIPERGLUCEMIC AGENT FOR THE PREPARATION OF A PHARMACEUTICAL MEDICINAL AND COMPOSITION THAT UNDERSTANDS SENSITIZER AND SUCH AGENT